VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma.
Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma. Clin Cancer Res. 2018 05 15; 24(10):2304-2311.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Autografts
Biomarkers, Tumor
Carmustine
Cause of Death
Clinical Trials, Phase II as Topic
Combined Modality Therapy
Cytarabine
Disease-Free Survival
Etoposide
Female
Graft Survival
Hematopoietic Stem Cell Transplantation
Humans
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse
Male
Melphalan
Middle Aged
Prognosis
Randomized Controlled Trials as Topic
Retreatment
Rituximab
Treatment Outcome
Young Adult
Yttrium Radioisotopes
authors with profiles
MARTIN KORBLING
ISSA F KHOURI
LUIS E FAYAD
PAOLO ANDERLINI
L JEFFREY MEDEIROS
HOMER A MACAPINLAC
ELIAS JOSEPH JABBOUR
BETUL ORAN
STEFAN OCTAVIAN CIUREA
KEN HE YOUNG
SAIRAH AHMED